Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014

  • Kim, Deog Kyeom (Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine) ;
  • Park, Yong Bum (Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Kangdong Sacred Heart Hospital) ;
  • Oh, Yeon-Mok (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jung, Ki-Suck (Division of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital) ;
  • Yoo, Ji Hong (Department of Pulmonary and Critical Care Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine) ;
  • Yoo, Kwang-Ha (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Kim, Kwan Hyung (Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2015.12.01
  • Accepted : 2015.12.21
  • Published : 2016.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Asthma is a prevalent and serious health problem in Korea. Recently, the Korean Asthma Guideline has been updated by The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) in an effort to improve the clinical management of asthma. This guideline focuses on adult patients with asthma and aims to deliver up to date scientific evidence and recommendations to general physicians for the management of asthma. For this purpose, this guideline was updated following systematic review and meta-analysis of recent studies and adapting some points of international guidelines (Global Initiative for Asthma [GINA] report 2014, National Asthma Education and Prevention Program [NAEPP] 2007, British Thoracic Society [BTS/SIGN] asthma guideline 2012, and Canadian asthma guideline 2012). Updated issues include recommendations derived using the population, intervention, comparison, and outcomes (PICO) model, which produced 20 clinical questions on the management of asthma. It also covers a new definition of asthma, the importance of confirming various airflow limitations with spirometry, the epidemiology and the diagnostic flow of asthma in Korea, the importance and evidence for inhaled corticosteroids (ICS) and ICS/formoterol as a single maintenance and acute therapy in the stepwise management of asthma, assessment of severity of asthma and management of exacerbation, and an action plan to cope with exacerbation. This guideline includes clinical assessments, and treatment of asthma-chronic obstructive pulmonary disease overlap syndrome, management of asthma in specific conditions including severe asthma, elderly asthma, cough variant asthma, exercise-induced bronchial contraction, etc. The revised Korean Asthma Guideline is expected to be a useful resource in the management of asthma.

Keywords

References

  1. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach [Internet]. Geneva: World Health Organization; 2007 [cited 2016 Jan 3]. Available from: http://www.who.int/gard/publications/GARD_Manual/en/.
  2. Park HS, Choi GS, Cho JS, Kim YY. Epidemiology and current status of allergic rhinitis, asthma, and associated allergic diseases in Korea: ARIA Asia-Pacific workshop report. Asian Pac J Allergy Immunol 2009;27:167-71.
  3. The clinical guideline of bronchial asthma [Internet]. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases; 2005 [cited 2016 Jan 3]. Available from: http://www.lungkorea.org/thesis/guide.php.
  4. The Korean Academy of Tuberculosis and Respiratory Diseases. The Korean asthma guideline for adults: revised in 2014. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases; 2014.
  5. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop report. Bethesda: National Heart, Lung and Blood Institute, National Institutes of Health; 2014.
  6. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120(5 Suppl):S94-138. https://doi.org/10.1016/j.jaci.2007.09.029
  7. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008;63 Suppl 4:iv1-121. https://doi.org/10.1136/thx.2008.097741
  8. Lougheed MD, Leniere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults: executive summary. Can Respir J 2012;19:e81-8. https://doi.org/10.1155/2012/214129
  9. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839-42. https://doi.org/10.1503/cmaj.090449
  10. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490. https://doi.org/10.1136/bmj.328.7454.1490
  11. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011;64:380-2. https://doi.org/10.1016/j.jclinepi.2010.09.011
  12. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78. https://doi.org/10.1111/j.1398-9995.2004.00526.x
  13. Cho SH, Park HW, Rosenberg DM. The current status of asthma in Korea. J Korean Med Sci 2006;21:181-7. https://doi.org/10.3346/jkms.2006.21.2.181
  14. Lee YH, Yoon SJ, Kim EJ, Kim YA, Seo HY, Oh IH. Economic burden of asthma in Korea. Allergy Asthma Proc 2011;32:35-40. https://doi.org/10.2500/aap.2011.32.3479
  15. Statics Korea. Annual report on the cause of death statistics. Daejeon: Statics Korea; 2013.
  16. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145(4 Pt 1):890-9. https://doi.org/10.1164/ajrccm/145.4_Pt_1.890
  17. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990;142:832-6. https://doi.org/10.1164/ajrccm/142.4.832
  18. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma: formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-11. https://doi.org/10.1056/NEJM199711133372001
  19. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6. https://doi.org/10.1056/NEJM200008033430504
  20. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010;(5):CD005535.
  21. Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev 2013;(4):CD007313.
  22. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99. https://doi.org/10.1164/rccm.200801-060ST
  23. Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 2001;(1):CD001740.
  24. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999;281:2119-26. https://doi.org/10.1001/jama.281.22.2119
  25. Kerstjens HA, Disse B, Schroder-Babo W, Bantje TA, Gahlemann M, Sigmund R, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011;128:308-14. https://doi.org/10.1016/j.jaci.2011.04.039
  26. Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012;367:1198-207. https://doi.org/10.1056/NEJMoa1208606
  27. Chauhan BF, Ducharme FM. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev 2014;(1):CD003137.
  28. Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet 2001;357:2007-11. https://doi.org/10.1016/S0140-6736(00)05113-8
  29. D'Amato G, Stanziola A, Sanduzzi A, Liccardi G, Salzillo A, Vitale C, et al. Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review. Multidiscip Respir Med 2014;9:23. https://doi.org/10.1186/2049-6958-9-23
  30. Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev 2014;(1):CD003559.
  31. Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade Lima M, Shah PL, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010;181:116-24. https://doi.org/10.1164/rccm.200903-0354OC
  32. Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, et al. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulm Med 2011;11:8. https://doi.org/10.1186/1471-2466-11-8
  33. Brusselle GG, Vanderstichele C, Jordens P, Deman R, Slabbynck H, Ringoet V, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 2013;68:322-9. https://doi.org/10.1136/thoraxjnl-2012-202698
  34. Cameron EJ, Chaudhuri R, Mair F, McSharry C, Greenlaw N, Weir CJ, et al. Randomised controlled trial of azithromycin in smokers with asthma. Eur Respir J 2013;42:1412-5. https://doi.org/10.1183/09031936.00093913
  35. Parsons JP, Hallstrand TS, Mastronarde JG, Kaminsky DA, Rundell KW, Hull JH, et al. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2013;187:1016-27. https://doi.org/10.1164/rccm.201303-0437ST
  36. Gluck JC, Gluck PA. The effect of pregnancy on the course of asthma. Immunol Allergy Clin North Am 2006;26:63-80. https://doi.org/10.1016/j.iac.2005.10.008

Cited by

  1. The Need for a Well-Organized, Video-Assisted Asthma Education Program at Korean Primary Care Clinics vol.80, pp.2, 2016, https://doi.org/10.4046/trd.2017.80.2.169
  2. Asthma-COPD Overlap Shows Favorable Clinical Outcomes Compared to Pure COPD in a Korean COPD Cohort vol.9, pp.5, 2017, https://doi.org/10.4168/aair.2017.9.5.431
  3. 성인 천식환자의 자가감시 연계 활동계획서 교육이 자가관리 이행, 지식, 증상조절 및 삶의 질에 미치는 효과: 무작위대조시험설계 vol.47, pp.5, 2016, https://doi.org/10.4040/jkan.2017.47.5.613
  4. Association between age at asthma diagnosis and tooth loss vol.76, pp.7, 2018, https://doi.org/10.1080/00016357.2018.1436723
  5. Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model vol.23, pp.5, 2018, https://doi.org/10.1080/1354750x.2018.1443510
  6. Increased Risk of Exacerbation in Asthma Predominant Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome vol.81, pp.4, 2016, https://doi.org/10.4046/trd.2017.0064
  7. Regular follow-up visits reduce the risk for asthma exacerbation requiring admission in Korean adults with asthma vol.14, pp.None, 2016, https://doi.org/10.1186/s13223-018-0250-0
  8. Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma vol.11, pp.4, 2019, https://doi.org/10.4168/aair.2019.11.4.508
  9. Dilemma of Asthma Treatment in Mild Patients vol.82, pp.3, 2016, https://doi.org/10.4046/trd.2018.0013
  10. Real‐life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred‐dose inhalers in patients with asthma treated with ICS/LABA vol.24, pp.10, 2016, https://doi.org/10.1111/resp.13559
  11. Increasing Prevalence and Mortality of Asthma With Age in Korea, 2002–2015: A Nationwide, Population-Based Study vol.12, pp.3, 2016, https://doi.org/10.4168/aair.2020.12.3.467
  12. Inverse Relationship between Adenoid Size and Asthma or Atopy in Children: A Preliminary Study vol.63, pp.9, 2020, https://doi.org/10.3342/kjorl-hns.2019.00913
  13. The Status and Influencing Factors of Respiratory System Diseases in Korean Farmers with Disease vol.31, pp.4, 2016, https://doi.org/10.7856/kjcls.2020.31.4.779
  14. Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population vol.8, pp.1, 2016, https://doi.org/10.1136/bmjresp-2020-000856
  15. Mortality and morbidity in children with asthma: A nationwide study in Korea vol.177, pp.None, 2016, https://doi.org/10.1016/j.rmed.2021.106306
  16. Diagnostic value of the hypertonic saline bronchial provocation test in children with asthma using the high-power aerosol provocation system vol.58, pp.5, 2016, https://doi.org/10.1080/02770903.2020.1713148
  17. Does the Use of Asthma-Controller Medication in Accordance with Guidelines Reduce the Incidence of Acute Exacerbations and Healthcare Costs? vol.85, pp.1, 2016, https://doi.org/10.4046/trd.2021.0087